Valerie Proulle

Reims, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Unmet needs despite standard-of-care prophylaxis in Hemophilia A: improved outcomes after switching to Efanesoctocog Alfa.

Unmet needs despite standard-of-care prophylaxis in Hemophilia A: improved outcomes after switching to Efanesoctocog Alfa.

Journal: Blood advances
Published: March 13, 2026

Real-World Effectiveness and Safety of Concizumab Prophylaxis in Hemophilia: Results From a National French Cohort.

Real-World Effectiveness and Safety of Concizumab Prophylaxis in Hemophilia: Results From a National French Cohort.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 25, 2026

How to Manage Venous Thromboembolism Risk during Pregnancy in Patients with Inherited Antithrombin Deficiency?

How to Manage Venous Thromboembolism Risk during Pregnancy in Patients with Inherited Antithrombin Deficiency?

Journal: Thrombosis and haemostasis
Published: July 08, 2025

Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome.

Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome.

Journal: Haematologica
Published: August 09, 2024

Cross-reactivity of human anti-FVIII antibodies to porcine rFVIII: French field study to validate the modified Nijmegen method.

Cross-reactivity of human anti-FVIII antibodies to porcine rFVIII: French field study to validate the modified Nijmegen method.

Journal: International journal of laboratory hematology
Published: April 09, 2024

Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?

Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?

Journal: Thrombosis research
Published: January 03, 2024

High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitro.

High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitro.

Journal: Journal of thrombosis and haemostasis : JTH
Published: September 15, 2023

Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.

Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.

Journal: Journal of thrombosis and haemostasis : JTH
Published: January 26, 2023

Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy.

Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy.

Journal: Journal of thrombosis and haemostasis : JTH
Published: January 01, 2023

The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice.

The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice.

Journal: Haematologica
Published: August 05, 2022

A thrombopoietin receptor agonist to rescue an unusual platelet transfusion-induced reaction in a p.V1316M-associated von Willebrand disease type 2B patient.

A thrombopoietin receptor agonist to rescue an unusual platelet transfusion-induced reaction in a p.V1316M-associated von Willebrand disease type 2B patient.

Journal: Therapeutic advances in hematology
Published: August 19, 2021

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter.

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter.

Journal: Frontiers in medicine
Published: March 20, 2021
Showing 1-12 of 38

Last Updated: 09/26/2026